Rui Lin

1.8k citations
53 papers · 1.4k indexed · h-index 20

Impact in

Papers in

    • Liver Diseases and Immunity 5
    • MicroRNA in disease regulation 6
    • Cancer-related molecular mechanisms research 6

Rui Lin

52 papers receiving 1.3k citations

Peers

Rui Lin
Comparison fields: 5 of 127
  • Biological Psychiatry 42
  • Hepatology 110
  • Cancer Research 172
  • Molecular Biology 667
  • Pathology and Forensic Medicine 132
Replace Yunhuan Liu with:
Yunhuan Liu China
Weiwei Jiang China
Yinglei Miao China
Liya Yang China
Pedro A. Ruiz Switzerland
Ankur Seth United States
Hao Ren China
Lydie Humbert France
Sabrina Krautbauer Germany
Rui Lin relative to Yunhuan Liu China Yunhuan Liu's profile →
Citations per field
00.5×
Yunhuan Liu · 1×
Citations per year

Countries citing papers authored by Rui Lin

Since Specialization
Citations

This map shows the geographic impact of Rui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Lin more than expected).

Fields of papers citing papers by Rui Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Lin. The network helps show where Rui Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Rui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rui Lin Line = papers co-authored together Rui Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20241
3 20241
4 20227
5 20225
6 20225
7 202212
8 202015
9 202076
10 201922
11 201845
12 201819
13 201712
14 201622
15 20164
16 201522
17 201529
18 201327
19 20098
20 200727

About Rui Lin

Rui Lin is a scholar working on Hepatology, Cancer Research, Aging, Biotechnology and Pathology and Forensic Medicine, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Liver Diseases and Immunity (5 papers), RNA modifications and cancer (5 papers), Immune Cell Function and Interaction (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Biological Psychiatry (42 citations), Hepatology (110 citations), Cancer Research (172 citations), Molecular Biology (667 citations) and Pathology and Forensic Medicine (132 citations). Rui Lin has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Meiyu Piao, Yan Song, Wentian Liu, Zhu Hong, Bangmao Wang, Lu Zhou, Xiaoli Li, Jiansheng Li, Jie Zhang and Chunyan Liu. Their work appears in journals such as Vaccine, Digestive Diseases and Sciences, Biotechnology Progress, International Immunopharmacology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026